TY - JOUR
T1 - Prevalence of hypertension and rate of blood pressure control as assessed by home blood pressure measurements in a rural Japanese community, Ohasama
AU - Nagai, Kenichi
AU - Imai, Yutaka
AU - Tsuji, Ichiro
AU - Ohkubo, Takayoshi
AU - Sakuma, Mariko
AU - Watanabe, Noriko
AU - Kato, Junko
AU - Kikuchi, Noriko
AU - Nishiyama, Akimitsu
AU - Sekino, Makoto
AU - Itoh, Osamu
AU - Satoh, Hiroshi
AU - Hisamichi, Shigeru
AU - Abe, Keishi
N1 - Funding Information:
This work was supported by a Research Grant from the Miyagi Prefectural Kidney Association, a Research Grant from the Takeda Medical Research Foundation, a Research Grant for Cardiovascular Disease (No.4C-3, 5C-2), a Research Grant entitled “Evaluation of the effect of drug treatment on hypertension and other chronic disease conditions in the elderly” from the Ministry of Health and Welfare, and by a Research Grant for the Scientific Research (07670420) from the Ministry of Education, Science and Culture of Japan.
PY - 1996
Y1 - 1996
N2 - A cross-sectional community survey using home blood pressure measurements was performed in northern Japan to estimate the prevalence of definite hypertension, white coat hypertension and the success of blood pressure control in patients receiving antihypertensive drugs. A total of 1334 subjects (mean age ± SD, 53.8 ± 17.3 years; 8-91 years) participated in the screening and home blood pressure measurement program. They measured blood pressure at home at least 3 times (mean measurement frequency, 20.8 ± 8.3 times). Of these 1334 subjects, 314 (65.1 ± 8.9 years) were taking drugs (treated group) while 1020 (50.3 ± 17.8 years) were not (untreated group). The WHO criteria were used to categorize screening blood pressure. Criteria for diagnosis of hypertension by home blood pressure measurements were as follows: definitely hypertensive (systolic blood pressure ≥144 mmHg and/or diastolic blood pressure ≥89 mmHg) and normotensive (104 < systolic blood pressure ≤ 131 mmHg and 60 < diastolic blood pressure ≤79 mmHg). Of the 1018 subjects identified as normotensive on screening measurements, home measurements indicated that 73 (7.2%) were hypertensive and 765 (74.7%) were normotensive or lower. Of the 112 subjects identified as hypertensive on screening measurements, home measurements showed that 42 (37.5%) were hypertensive and 30 (26.8%) were normotensive or lower. Of the 314 treated subjects, 45 (14.3%) were identified as hypertensive by screening measurements and 88 (28.0%) as hypertensive by home measurements. Only 20 (44.4%) of the former 45 subjects were also defined as definitely hypertensive by home measurements. Of the 1020 untreated subjects, 67 (6.6%) were hypertensive by screening measurements and 84 (8.2%) by home measurements. Only 22 (32.8%) of the former 67 subjects were classified as hypertensive by home measurements. Of the 67 untreated subjects identified as hypertensive by screening measurements, 20 (29.9%) were normotensive or lower by home measurements, suggesting that these subjects were 'white coat' hypertensives. The study first confirmed based on the large community data that there are large discrepancies between screening (casual) blood pressure and home blood pressure measurements for recognition of hypertension and normotension. Determination of blood pressure levels by home blood pressure measurements may predict prognosis of hypertension differently from that by screening blood pressure measurements. Further prospective study is needed to validate the prognostic value of home blood pressure measurements.
AB - A cross-sectional community survey using home blood pressure measurements was performed in northern Japan to estimate the prevalence of definite hypertension, white coat hypertension and the success of blood pressure control in patients receiving antihypertensive drugs. A total of 1334 subjects (mean age ± SD, 53.8 ± 17.3 years; 8-91 years) participated in the screening and home blood pressure measurement program. They measured blood pressure at home at least 3 times (mean measurement frequency, 20.8 ± 8.3 times). Of these 1334 subjects, 314 (65.1 ± 8.9 years) were taking drugs (treated group) while 1020 (50.3 ± 17.8 years) were not (untreated group). The WHO criteria were used to categorize screening blood pressure. Criteria for diagnosis of hypertension by home blood pressure measurements were as follows: definitely hypertensive (systolic blood pressure ≥144 mmHg and/or diastolic blood pressure ≥89 mmHg) and normotensive (104 < systolic blood pressure ≤ 131 mmHg and 60 < diastolic blood pressure ≤79 mmHg). Of the 1018 subjects identified as normotensive on screening measurements, home measurements indicated that 73 (7.2%) were hypertensive and 765 (74.7%) were normotensive or lower. Of the 112 subjects identified as hypertensive on screening measurements, home measurements showed that 42 (37.5%) were hypertensive and 30 (26.8%) were normotensive or lower. Of the 314 treated subjects, 45 (14.3%) were identified as hypertensive by screening measurements and 88 (28.0%) as hypertensive by home measurements. Only 20 (44.4%) of the former 45 subjects were also defined as definitely hypertensive by home measurements. Of the 1020 untreated subjects, 67 (6.6%) were hypertensive by screening measurements and 84 (8.2%) by home measurements. Only 22 (32.8%) of the former 67 subjects were classified as hypertensive by home measurements. Of the 67 untreated subjects identified as hypertensive by screening measurements, 20 (29.9%) were normotensive or lower by home measurements, suggesting that these subjects were 'white coat' hypertensives. The study first confirmed based on the large community data that there are large discrepancies between screening (casual) blood pressure and home blood pressure measurements for recognition of hypertension and normotension. Determination of blood pressure levels by home blood pressure measurements may predict prognosis of hypertension differently from that by screening blood pressure measurements. Further prospective study is needed to validate the prognostic value of home blood pressure measurements.
KW - home blood pressure measurements
KW - screening blood pressure
KW - sensitivity
KW - specificity
KW - white coat hypertension
UR - http://www.scopus.com/inward/record.url?scp=15844409179&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=15844409179&partnerID=8YFLogxK
U2 - 10.3109/10641969609081776
DO - 10.3109/10641969609081776
M3 - Article
C2 - 8781755
AN - SCOPUS:15844409179
VL - 18
SP - 713
EP - 728
JO - Clinical and Experimental Hypertension
JF - Clinical and Experimental Hypertension
SN - 1064-1963
IS - 5
ER -